GBS/CIDP Foundation International

Recent papers from GBS/CIDP Foundation International

1. Impact of fatigue and disability on health-related quality of life in CIDP: Results from an international surveyClinical Neurology and Neurosurgery · 2026
2. Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating PolyradiculoneuropathyNeurology · 2026
3. Acute and Chronic Life-altering Consequences of Guillain-Barré Syndrome: A Qualitative Study Identifies Significant Unmet Need for Timely Diagnosis and Appropriate Treatment (P3-19.005)Neurology · 2026
4. Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice ExperimentNeurology and Therapy · 2026
5. The journey to diagnosis for patients with CIDP: results from a real-world international surveyFrontiers in Neurology · 2026
6. Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trialTherapeutic Advances in Neurological Disorders · 2026
7. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndromeEuropean Journal of Neurology · 2023
8. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndromeJournal of the Peripheral Nervous System · 2023
9. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revisionEuropean Journal of Neurology · 2021
10. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revisionJournal of the Peripheral Nervous System · 2021
11. A Global Survey of Disease Burden in Patients Who Carry a Diagnosis of Chronic Inflammatory Demyelinating PolyneuropathyAdvances in Therapy · 2020
12. Chronic Inflammatory Demyelinating Polyradiculoneuropathy 101—Pitfalls and Pearls of Diagnosis and TreatmenttouchREVIEWS in Neurology · 2017
13. Risk‐based decision making and ethical considerations in donor compensation for plasma‐derived medicinal productsTransfusion · 2016
14. New Insights Into the Management of Chronic Inflammatory Demyelinating PolyradiculoneuropathyNeurodegenerative Disease Management · 2015